loading page

Methotrexate Monotherapy for Unilateral Active Thyroid-Related Eye Disease
  • Ayman Elnahry,
  • Joseph Talbet,
  • Gehad Elnahry
Ayman Elnahry
Cairo University Kasr Alainy Faculty of Medicine
Author Profile
Joseph Talbet
Howard University College of Medicine
Author Profile
Gehad Elnahry
Cairo University Kasr Alainy Faculty of Medicine
Author Profile

Abstract

A type 1 diabetic patient with unilateral active thyroid-related eye disease was intolerant to systemic steroid therapy due to uncontrollable blood sugar levels. She was treated with low-dose methotrexate monotherapy which resulted in a marked improvement of her condition with no adverse events.

Peer review status:UNDER REVIEW

10 Apr 2021Submitted to Clinical Case Reports
12 Apr 2021Assigned to Editor
12 Apr 2021Submission Checks Completed
22 Apr 2021Reviewer(s) Assigned